BMS 150 mg 3624 (Reyataz 150 mg)

Generic Name: atazanavir

Pill imprint BMS 150 mg 3624 has been identified as Reyataz 150 mg.

Reyataz is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Reyataz 150 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for BMS 150 mg 3624

Reyataz 150 mg BMS 150 mg 3624 Front
Reyataz 150 mg BMS 150 mg 3624 Back
Reyataz 150 mg BMS 150 mg 3624
Reyataz
Generic Name:
atazanavir
Imprint:
BMS 150 mg
3624
Strength:
150 mg
Color:
Blue
Size:
19.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Protease inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Bristol-Myers Squibb
National Drug Code (NDC):
00003-3624
Inactive Ingredients:
crospovidone
lactose monohydrate
magnesium stearate
gelatin
FD&C Blue No. 2
titanium dioxide
ferric oxide red
ferric oxide yellow
isopropyl alcohol
ammonia
propylene glycol
butyl alcohol
alcohol
ferrosoferric oxide
shellac
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68258-9142 Dispensing Solutions Inc. (repackager)
35356-0068 Lake Erie Medical and Surgical Supply (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)